Abstract
Background
Thyroidectomy is the typical treatment for pediatric thyroid carcinoma; total thyroidectomy is commonly performed. We aimed to report our experience at a single tertiary institution and to evaluate the risk factors for recurrence, especially based on surgical extent, in pediatric patients with differentiated thyroid carcinoma (DTC).
Methods
A data of 94 pediatric patients who underwent thyroid surgery for DTC from January 1982 to December 2012 at Yonsei University Hospital (Seoul, Korea) were reviewed. The clinicopathologic features and surgical outcomes were retrospectively analyzed through complete chart reviews.
Results
The mean age was 16.6 ± 3.0 (range, 5–19) years. Fourteen patients had recurrence. Tumor size >2 cm (hazard ratio [HR], 14.241; p = 0.011) and positive lymph nodes (HR, 1.056; p = 0.039) were significant risk factors for disease-free survival (DFS) in multivariate analysis. In Kaplan–Meier analysis, a statistically significant difference was noted in the DFS according to tumor size 2 cm (p < 0.001). However, the DFS was not significantly different between the bilateral total thyroidectomy (BTT) and less than BTT groups (p = 0.215).
Conclusions
BTT remains the treatment of choice in pediatric patients with DTC. Lobectomy may be considered for patients with limited disease, including those with tumor size <2 cm, no suspicious lymph nodes, intrathyroidal lesion, and no multifocal disease.
Similar content being viewed by others
Change history
22 September 2020
The article ���Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution���, written by Kim et al., was originally published electronically on the publisher���s internet portal (currently SpringerLink) on May 21, 2020, with open access. With the authors��� decision to step back from Open Choice, the copyright of the article changed on September 14, 2020 to �� Soci��t�� Internationale de Chirurgie 2020 and the article is forthwith distributed under the terms of copyright. The original article has been corrected.
References
Howlader N, Noone A, Krapcho M et al (2012) SEER cancer statistics review, 1975–2009 (vintage 2009 populations)
Park S, Jeong JS, Ryu HR et al (2013) Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system. J Korean Med Sci 28:693–699
Holmes L, Hossain J, Opara F (2012) Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973–2007): race or shifting diagnostic paradigm? ISRN Oncol 2012:1–10
Demidchik YE, Demidchik EP, Reiners C et al (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 243:525
Demidchik V, Shabala SN, Davies JM (2007) Spatial variation in H2O2 response of Arabidopsis thaliana root epidermal Ca2+ flux and plasma membrane Ca2+ channels. Plant J 49:377–386
Welch Dinauer CA, Robie DK, McClellan DR et al (1998) Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol 49:619–628
Lazar L, Lebenthal Y, Steinmetz A et al (2009) Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr 154:708–714
La Quaglia MP, Black T, Holcomb GW et al (2000) Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 35:955–960
Grigsby PW, Gal-or A, Michalski JM et al (2002) Childhood and adolescent thyroid carcinoma. Cancer 95:724–729
Dinauer CA, Breuer C, Rivkees SA (2008) Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol 20:59–65
Papendieck P, Gruñeiro-Papendieck L, Venara M et al (2011) Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents. J Pediatr Endocrinol Metab 24:743–748
Alzahrani AS, Alkhafaji D, Tuli M et al (2016) Comparison of differentiated thyroid cancer in children and adolescents (≤ 20 years) with young adults. Clin Endocrinol 84:571–577
Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on pediatric thyroid cancer. Thyroid 25:716–759
Handkiewicz-Junak D, Wloch J, Roskosz J et al (2007) Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 48:879–888
Spencer CA, LoPresti JS (2008) Technology insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 4:223–233
Van Santen H, Aronson D, Vulsma T et al (2004) Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. Eur J Cancer 40:1743–1751
Rachmiel M, Charron Μ, Gupta A et al (2006) Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab 19:1377–1394
Kundel A, Thompson G, Richards M et al (2014) Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic. J Clin Endocrinol Metab 99:399–406
Angelos P (2009) Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. Surg Clin North Am 89:1157–1169
Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202. https://doi.org/10.1007/s00268-009-0364-0
Oh C-M, Won Y-J, Jung K-W et al (2016) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 48:436
Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Prev Biomark 18:784–791
Collini P, Massimino M, Leite SF et al (2006) Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the istituto nazionale tumori in Milan. Pediatr Blood Cancer 46:300–306
Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 156:167–172
Farahati J, Bucsky P, Parlowsky T et al (1997) Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 80:2156–2162
Jarząb B, Junak DH, Włoch J et al (2000) Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med Mol Imaging 27:833–841
Astl J, Chovanec M, Lukeš P et al (2014) Thyroid carcinoma surgery in children and adolescents—15 years experience surgery of pediatric thyroid carcinoma. Int J Pediatr Otorhinolaryngol 78:990–994
Enomoto Y, Enomoto K, Uchino S et al (2012) Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg 36:1241–1246. https://doi.org/10.1007/s00268-012-1558-4
Byeon HK, Kim SB, Oh HS et al (2019) Clinical analysis of pediatric thyroid cancer: a single medical institution experience of 18 years. Ann Otol Rhinol Laryngol 128:1152–1157
Jeon MJ, Yoon JH, Han JM et al (2013) The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol 168:219–225
Rubinstein JC, Dinauer C, Herrick-Reynolds K et al (2019) Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer. J Pediatr Surg 54:129–132
Spinelli C, Strambi S, Rossi L et al (2016) Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients. J Endocrinol Investig 39:1055–1059
Massimino M, Gasparini M, Ballerini E et al (1995) Primary thyroid carcinoma in children: a retrospective study of 20 patients. Pediatr Blood Cancer 24:13–17
Acknowledgements
I would like to thank all nurse helping the operations who have contributed to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised: This article was originally published electronically on the publisher’s internet portal (currently SpringerLink) on May 21, 2020, with open access. With the authors’ decision to step back from Open Choice, the copyright of the article was changed to Société Internationale de Chirurgie and the article is forthwith distributed under the terms of copyright.
Rights and permissions
About this article
Cite this article
Kim, K., Lee, C.R., Kang, SW. et al. Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution. World J Surg 44, 3383–3392 (2020). https://doi.org/10.1007/s00268-020-05598-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-020-05598-9